Keywords: blow, astrazeneca, fda, panel, votes, against, otc

Blow for AstraZeneca as FDA panel votes against OTC omeprazole at this time

Article | 23 October 2000

Print This

AstraZeneca has been told by a joint US Food and Drug Administrationadvisory committee that it has decided not to recommend ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in